Views & Analysis Scientific evidence ‘on demand’? Proceedings from an expert ... The ways in which we communicate and consume information are constantly transforming.
Views & Analysis Alexion’s Camilla Harder Hartvig on making the impossible po... Alexion’s senior vice president of its international business talks to Paul Tunnah about the importance of “people-centred and vulnerable” leadership, the surprising impacts of COVID and th
Views & Analysis How COVID-19 has changed the role of pharma sales reps The demise of the pharmaceutical sales representative has been greatly exaggerated over the years.
Views & Analysis What CX Tech Innovations Options Are Ripe for Consideration? Innovation is often driven by frustration.
Views & Analysis Why pharma isn’t yet achieving digital excellence, and how i... Nearly 70% of HCPs are now digital natives, with no interest in going back to pre-COVID sales engagement methods.
Views & Analysis Reality Check | Is Your Current Customer Engagement Solution... Do your sales reps drive a Ferrari? Probably not. Would they like one if you offered it to them? Probably.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
